Patent · US Active

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US11052061B2 · kind B2 · utility

29Cited by

43References

24Claims

0Family size

Assignee

Flamel Ireland Limited · IE

Inventors

Claire Mégret · L'Essart Mador, FR
Hervé Guillard · Villeurbanne, FR
Jean-François Dubuisson · L'Essart Mador, FR

Key dates

Filing date	May 22, 2019
Grant date	Jul 6, 2021
Priority date	—
Expiry date	May 22, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.